EN
HI
Summary
As of 11 Nov, 2026, Jenburkt Pharmaceuticals stock price is ₹953.75. During the trading session, the stock has moved between an intraday low of ₹951.20 and an intraday high of ₹980.00. Over the last 52 weeks, Jenburkt Pharmaceuticals has traded between ₹845.00 and ₹1073.90.
The stock has recorded a trading volume of 543 shares,. Its Average Traded Price (ATP) is ₹953.48, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 70 @ ₹953.75.
Jenburkt Pharmaceuticals has an upper circuit limit of ₹1144.50 and a lower circuit limit of ₹763.00. The total value traded stands at ₹5.18 L, and the delivery percentage for the day is 70.35%.
The stock is currently traded with a market lot size of 1. Jenburkt Pharmaceuticals also offers a dividend yield of 0%.
Jenburkt Pharmaceuticals Share Price Chart
Jenburkt Pharmaceuticals Share Key Metrics
Volume
543.00
Market Cap
420.92 CR
LTQ@LTP
70@953.75
ATP
953.48
Var Margin
17.33 %
Circuit Range
763-1144.5
Delivery %
70.35 %
Value
5.18 L
ASM/GSM
No
Market Lot
1
Jenburkt Pharmaceuticals Resistance and Support
Pivot 961.65
Resistance
First Resistance
972.1
Second Resistance
990.45
Third Resistance
1000.9
Support
First Support
943.3
Second Support
932.85
Third Support
914.5
Jenburkt Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Mon Nov 09 2026 | 980 | 953.75 | -2.08% | 980 | 951.2 |
| Sun Nov 08 2026 | 966.59 | 974 | 3.51% | 977.7 | 947 |
| Fri Nov 06 2026 | 917.59 | 940.95 | -0.32% | 948.4 | 917.59 |
Jenburkt Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-03 | Quarterly Results |
| 2026-08-06 | Quarterly Results |
| 2026-05-05 | Audited Results |
| 2026-02-03 | Quarterly Results |
| 2025-10-28 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-20 | Audited Results & Final Dividend |
| 2025-01-28 | Quarterly Results |
| 2024-11-05 | Quarterly Results |
Jenburkt Pharmaceuticals News
Jenburkt Pharmaceuticals Ltd - 524731 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Counter Cyclical Investments Private Limited acquired 4,608 shares (0.10% stake) of Jenburkt Pharmaceuticals via the open market on 03 Nov 2026. Following this, their total shareholding has increased to 5.11%.
Nov 04 2026 15:50:42
Jenburkt Pharmaceuticals Ltd - 524731 - Board Meeting Outcome for Outcome Of The Board Meeting Held Today On 03Rd November, 2026.
Jenburkt Pharmaceuticals reported Q2 revenue of ₹48.32 crore, up 6% YoY, and a flat net profit of ₹10.21 crore. The half-year net profit declined to ₹16.10 crore compared to ₹17.96 crore in the previous year.
Nov 03 2026 18:00:33
Jenburkt Pharmaceuticals Management
| Name | Position |
|---|---|
| Ashish U Bhuta | Chairman & Managing Director |
| Dilip H Bhuta | Whole Time Director & Chief Financial Officer |
Jenburkt Pharmaceuticals FAQs
The Buying Price of Jenburkt Pharmaceuticals share is 953.75 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Jenburkt Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Jenburkt Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Jenburkt Pharmaceuticals shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Jenburkt Pharmaceuticals shares is 0. Useful to assess the stock's value relative to its book value.
To assess Jenburkt Pharmaceuticals’s valuation compare Sector P/E, P/B which are 40.97 & 3.85 with sector averages, along with growth rates and financial metrics.
The Market Cap of Jenburkt Pharmaceuticals is 420.92 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Jenburkt Pharmaceuticals share price is 1073.90 & 845.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Jenburkt Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in JENBURPH
